Neuphoria Therapeutics Inc. · NASDAQ:NEUP
Lynx1 Capital Management LP reported a 16.30% stake in Neuphoria Therapeutics Inc. (Schedule 13D/A)
Event Dec 26, 2025 · Filed Dec 29, 2025
Lynx1 Capital Management LP reported a 16.30% stake in Neuphoria Therapeutics Inc., 875,328 shares, with active intent on Dec 26, 2025. Filed Dec 29, 2025 (Schedule 13D/A).
- Stake
- 16.30%
- Shares
- 875,328
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Lynx1 Capital Management LP | 16.30% | 875,328 |
| Weston Nichols | 16.30% | 875,328 |
Source
Related
- Neuphoria Therapeutics Inc.
- Lynx1 Capital Management LP
- Neuphoria Therapeutics Inc. shareholders
- Schedule 13D/A · Lynx1 Capital Management LP · Dec 2, 2025
- Schedule 13D/A · Lynx1 Capital Management LP · Nov 28, 2025
- Schedule 13D/A · Lynx1 Capital Management LP · Nov 18, 2025
- Schedule 13D/A · Lynx1 Capital Management LP · Nov 10, 2025
- Schedule 13D · Lynx1 Capital Management LP · Oct 23, 2025
- Schedule 13G · AdvisorShares Trust · Oct 5, 2026
- Schedule 13G/A · Coastlands Capital LP · Jul 28, 2026
- Schedule 13G/A · Baselake Partners, LP · Feb 6, 2026
- Schedule 13G · Coastlands Capital LP · Nov 5, 2025
- Schedule 13G · Shay Capital LLC · Oct 31, 2025